Alcohol increases rectal cancer risk, but risk is smaller among regular wine drinkers

May 12, 2003

Regular drinkers significantly increase their risk of rectal cancer, but that risk is reduced if wine makes up a third or more of weekly consumption, suggests research in Gut.

The findings are based on a population study of over 29,000 Danish men and women aged between 23 and 95. Their weekly intake of beer, wine, and spirits was assessed, as were other factors likely to influence bowel cancer risk, such as how much they smoked, weighed, and took regular exercise.

Men were more likely than women to be heavy drinkers, and heavy drinkers were more likely to be smokers and to weigh more than light drinkers.

During a monitoring period of almost 15 years, 411 cases of colon cancer and 202 cases of rectal cancer were reported among those studied. Alcohol seemed to have little influence over the risk of colon cancer, but there was a clear association between rectal cancer risk and the amount of alcohol consumed. Those drinking more than 41 units of alcohol a week had twice the risk of developing the disease as non-drinkers.

But the type of alcohol consumed had a significant bearing on rectal cancer risk. Those who drank 14 or more units of beer or spirits a week were over 3.5 times as likely to develop rectal cancer as non-drinkers. Yet those who drank the same total amount of alcohol, but who included around a third or more of wine in their intake were less than twice as likely to develop the disease.

The authors point out that wine drinkers tended to be better educated and to take more exercise than beer or spirit drinkers, so there may be other healthier lifestyle factors at play.

There are no obvious reasons why alcohol should apparently be more damaging to the rectum than the colon, say the authors, but the reasons why wine seems to exert its protective effect most likely lie in resveratrol, which is found in both grapes and wine. Previous research indicates that this chemical damps down the cellular processes involved in the promotion and growth of cancerous cells.
-end-
Gut 2003; 52: 861-7

BMJ Specialty Journals

Related Colon Cancer Articles from Brightsurf:

New prognostic markers for colon cancer identified
The study recently published by MedUni Vienna and collaborative partners nominates ILSs as novel prognostic players orchestrating the pathobiology of metastatic colorectal cancer.

Turning colon cancer cells around
Using a modified natural substance along with current approaches could improve colon cancer treatment, according to findings by University of California, Irvine biologists.

Uncovering the pathway to colon cancer
The hidden world of genetic changes, or mutations, in healthy colon tissue has been uncovered by scientists at the Wellcome Sanger Institute and their collaborators.

Colon cancer growth reduced by exercise
Exercise may play a role in reducing the growth of colon cancer cells according to new research published in The Journal of Physiology.

Towards a better understanding of how colon cancer develops and progresses
Researchers from the University of Luxembourg have discovered a molecular mechanism that is responsible for the spread of cancer cells in the body and the development of metastases in patients with colon cancer.

New target protein for colon cancer identified
Researchers at Boston University School of Medicine (BUSM) have identified a new potential target protein (c-Cbl) they believe can help further the understanding of colon cancer and ultimately survival of patients with the disease.

Colon cancer -- Targeting tumor cell plasticity
Cell type switch helps colon cancer evade treatment, a study suggests.

A bacterial duo linked to colon cancer
Scientists have identified a combination of bacteria that appears to increase the risk of colon cancer.

New model could speed up colon cancer research
Using the CRISPR gene editing system, MIT researchers have shown they can generate colon tumors in mice that very closely resemble human colon tumors, an advance that should allow scientists to learn more about how the disease progresses and also help them test potential new drugs.

Are dialysis patients being over-screened for colon cancer?
Colonoscopies are being performed more often on healthier dialysis patients than on those with more limited life expectancies; however, overall, dialysis patients are being screened at a much higher rate relative to their life expectancy than their counterparts without kidney failure.

Read More: Colon Cancer News and Colon Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.